These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 27662586

  • 1. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.
    Zeber-Lubecka N, Kulecka M, Ambrozkiewicz F, Paziewska A, Goryca K, Karczmarski J, Rubel T, Wojtowicz W, Mlynarz P, Marczak L, Tomecki R, Mikula M, Ostrowski J.
    Gut Microbes; 2016 Sep 02; 7(5):397-413. PubMed ID: 27662586
    [Abstract] [Full Text] [Related]

  • 2. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y, Hong G, Yang M, Li G, Jin Y, Xiong H, Qian W, Hou X.
    Pharmacol Res; 2020 Sep 02; 159():104936. PubMed ID: 32470562
    [Abstract] [Full Text] [Related]

  • 3. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N, Ringel Y, Katibian D, Lundqvist A, Sartor RB, Carroll IM, Ringel-Kulka T.
    Dig Dis Sci; 2018 Jul 02; 63(7):1890-1899. PubMed ID: 29777439
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
    Jeffery IB, Das A, O'Herlihy E, Coughlan S, Cisek K, Moore M, Bradley F, Carty T, Pradhan M, Dwibedi C, Shanahan F, O'Toole PW.
    Gastroenterology; 2020 Mar 02; 158(4):1016-1028.e8. PubMed ID: 31843589
    [Abstract] [Full Text] [Related]

  • 10. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
    Chen J, Lan H, Li C, Xie Y, Cheng X, Xia R, Ke C, Liang X.
    J Appl Microbiol; 2024 Jun 03; 135(6):. PubMed ID: 38849305
    [Abstract] [Full Text] [Related]

  • 11. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
    Zhu S, Liu S, Li H, Zhang Z, Zhang Q, Chen L, Zhao Y, Chen Y, Gu J, Min L, Zhang S.
    Front Cell Infect Microbiol; 2019 Jun 03; 9():346. PubMed ID: 31681624
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
    Lyra A, Rinttilä T, Nikkilä J, Krogius-Kurikka L, Kajander K, Malinen E, Mättö J, Mäkelä L, Palva A.
    World J Gastroenterol; 2009 Dec 21; 15(47):5936-45. PubMed ID: 20014457
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.
    Pimentel M.
    Aliment Pharmacol Ther; 2016 Jan 21; 43 Suppl 1():37-49. PubMed ID: 26618924
    [Abstract] [Full Text] [Related]

  • 18. Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation.
    Ponziani FR, Pecere S, Lopetuso L, Scaldaferri F, Cammarota G, Gasbarrini A.
    Expert Opin Drug Saf; 2016 Jul 21; 15(7):983-91. PubMed ID: 27149541
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.
    Labus JS, Hollister EB, Jacobs J, Kirbach K, Oezguen N, Gupta A, Acosta J, Luna RA, Aagaard K, Versalovic J, Savidge T, Hsiao E, Tillisch K, Mayer EA.
    Microbiome; 2017 May 01; 5(1):49. PubMed ID: 28457228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.